Digestery
Everyday supplements › Fish Oil and the Heart › Studies

Other

Guideline for adults with high blood fats: EPA alone suggested, EPA plus DHA not

Patel and colleagues · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025

Original title: American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

Mixed

For adults with high triglycerides and heart disease or higher risk, the task force suggested EPA but not EPA plus DHA. It strongly recommended against niacin.

The study at a glance

Type of study
Other
Who or what was studied
adults with high blood fats at risk of heart disease, as covered by past trials
What was tested
Guideline on blood-fat drugs; for high triglycerides it covers EPA alone and EPA plus DHA
What it measured
The question itself: heart attacks, strokes and heart deaths
Who has a stake
No disclosure in PubMed
Disclosures are in an appendix not shown in PubMed.
Journal
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2025
Source
PubMed record 39919851. This page is based on the abstract only.

How much this study counts

  • •Another kind of paper. It carries no weight on the ladder.
  • •The PubMed record has no conflict-of-interest statement.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

This paper is not on the ladder. It is a other, and reviews and opinion pieces discuss studies that are already counted on the steps below.

↑ Stronger evidence

  1. Trials in people: heart attacks, strokes and heart deaths

    11

    7 benefit, 4 no difference

  2. Trials in people: other measures

    3

    1 benefit, 2 no difference

  3. Trials in people: lab tests or safety

    0

    None among the papers we read.

  4. Population studies

    0

    None among the papers we read.

  5. Blood levels and genes

    0

    None among the papers we read.

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does fish oil prevent heart disease?”

Little or no effect in most trials.

Confidence: moderate. Based on 21 on-topic papers.

Read the full answer

Other opinion on this question

See all 21 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The two reads differed. The reviewer checked the abstract and kept the first read. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.